Abstract: The embodiments herein relate to a method performed by a Control Plane (CP) function for handling a credit pool comprising granted service units to be used by multiple services. The multiple services are grouped in at least one first Rating Group (RG). The CP function creates an individual Usage Reporting Rule (URR) for each of the at least one first RG. Each individual URR comprises a first credit pool threshold. The CP function provides the individual URRs to a User Plane (UP) function. The CP function creates a Usage Reporting Rule for the Credit Pool (URR CRPL). The URR CRPL comprises instructions to the UP function to aggregate service unit usage for all individual URRs for all first RGs. The URR CRPL further comprises the first credit pool threshold. The CP function provides the URR CRPL to the UP function.

Abstract: A method performed in a CP node. The method comprises setting a TQM in a URR to which its corresponding SDFs are applicable for envelope reporting, setting at least one reporting trigger in the URR, to instruct the UP function to generate a usage report upon closure of an envelope, setting a measurement method in the URR, to instruct the UP function to collect usage of volume, time and/or event, sending the set URR to the UP function, receiving one or more usage reports from the UP function, in response to the sent URR, wherein the received usage report(s) comprises at least a usage report trigger set to envelope closure, determining a starting time and/or an ending time for each envelope, based on the received usage report(s), and storing each envelope, with the determined starting time and/or ending time, for online or offline charging.

Abstract: A method for supporting envelope reporting in a radio communication network having a control plane, CP, function separated from a user plane, UP, function, is presented.

Abstract: The embodiments herein relate to a method performed by a Control Plane (CP) function for handling a credit pool comprising granted service units to be used by multiple services. The multiple services are grouped in at least one first Rating Group (RG). The CP function creates an individual Usage Reporting Rule (URR) for each of the at least one first RG. Each individual URR comprises a first credit pool threshold. The CP function provides the individual URRs to a User Plane (UP) function. The CP function creates a Usage Reporting Rule for the Credit Pool (URR CRPL). The URR CRPL comprises instructions to the UP function to aggregate service unit usage for all individual URRs for all first RGs. The URR CRPL further comprises the first credit pool threshold. The CP function provides the URR CRPL to the UP function.

Abstract: The embodiments herein relate to a method performed by a Control Plane (CP) function (401) for handling a credit pool comprising granted service units to be used by multiple services. The multiple services are grouped in at least one first Rating Group (RG). The CP function (401) creates an individual Usage Reporting Rule (URR) for each of the at least one first RG. Each individual URR comprises a first credit pool threshold. The CP function provides the individual URRs to a User Plane (UP) function (405). The CP function (401) creates a Usage Reporting Rule for the Credit Pool (URR CRPL). The URR CRPL comprises instructions to the UP function (405) to aggregate service unit usage for all individual URRs for all first RGs. The URR CRPL further comprises the first credit pool threshold. The CP function (401) provides the URR CRPL to the UP function (405).

Abstract: A method for supporting envelope reporting in a radio communication network having a control plane, CP, function separated from a user plane, UP, function, is presented.

Abstract: A packet core system includes a User Plane, UP, a Control Plane, CP and an Online Charging System, OCS. The UP and CP are split, and the UP and CP allow communication over one or more SX interfaces. The UP is adapted for initially receiving a message such as a Sx/PFCP Session Establishment Request from the CR and responding with a message such as a Sx/PFCP Session Establishment Response to the CP, and receiving a message such as a Sx/PFCP Session Modification Request from the CP and responding with message such as a Sx/PFCP Modification Response to the CP. At least one of the Sx/PFCP Session Establishment Request and the SX/PFCP Session Modification Request includes a Generic Buffering Information Element indicating a generic buffering action.

Abstract: The embodiments herein relate to a method performed by a Control Plane (CP) function (401) for handling a credit pool comprising granted service units to be used by multiple services. The multiple services are grouped in at least one first Rating Group (RG). The CP function (401) creates an individual Usage Reporting Rule (URR) for each of the at least one first RG. Each individual URR comprises a first credit pool threshold. The CP function provides the individual URRs to a User Plane (UP) function (405). The CP function (401) creates a Usage Reporting Rule for the Credit Pool (URR CRPL). The URR CRPL comprises instructions to the UP function (405) to aggregate service unit usage for all individual URRs for all first RGs. The URR CRPL further comprises the first credit pool threshold. The CP function (401) provides the URR CRPL to the UP function (405).

Abstract: The present invention encompasses compounds of general formula (1) wherein A, B, X, R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.

Abstract: The present invention encompasses compounds of general formula (1) wherein A, B, X, Rl to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.

Abstract: The present invention encompasses compounds of general formula (1) wherein A, B, X, R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.

Abstract: The present invention encompasses compounds of general formula (1) wherein A, B, X, R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.

Abstract: The present invention encompasses compounds of general formula (1), wherein the groups R1 to R3 and L are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.

Abstract: The present invention encompasses compounds of general formula (1) wherein A, B, X, R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.

Abstract: The present invention includes compounds of general formula (1) wherein A, X, R1 and R2 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.

Abstract: The present invention encompasses compounds of general formula (1) wherein B, R1 to R5, Rx, m and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use in such treatment.

Abstract: The present invention includes compounds of general formula (1) wherein A, X, R1 and R2 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.

Abstract: The present invention encompasses compounds of general formulae (1a) and (1b) wherein the groups R1 to R5, A, Q, m, n, p and q are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use as medicaments.

Abstract: The present invention encompasses compounds of general formula (1) wherein A, B, R1-R3, Rx and n are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.

Abstract: Compounds of general formula (1) wherein A, B, R1 to R5, Rx m, n and p are defined as described in the specification, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and the use thereof [as] medicaments.